Browse Category

Investing News 8 October 2025 - 9 October 2025

BULLISH BREAKOUT: Google’s $3B Backstop Rockets TeraWulf (WULF) Stock to Multi-Year High

BULLISH BREAKOUT: Google’s $3B Backstop Rockets TeraWulf (WULF) Stock to Multi-Year High

Recent Developments Google-Backed AI Deals: In mid-August 2025 TeraWulf unveiled two 10-year co-location agreements with Fluidstack for AI workloads investors.terawulf.com investors.terawulf.com. These contracts (200+ MW at Lake Mariner) anchor ~$3.7 B of initial revenue (up to $8.7 B with extensions) investors.terawulf.com. Google
Bluejay Diagnostics (BJDX) Stock Skyrockets on Sepsis Test Hopes – What Investors Need to Know

Bluejay Diagnostics (BJDX) Stock Skyrockets on Sepsis Test Hopes – What Investors Need to Know

Company Overview: A Near-Patient Diagnostics Specialist Bluejay Diagnostics, Inc. is a small Massachusetts-based medical diagnostics company focused on rapid near-patient testing solutions for critical care settings stocktitan.net. The company’s mission is to improve emergency and intensive care outcomes by enabling
Stocks Soar to Record Highs, Gold Tops $4,000 – What’s Driving 2025’s Historic Rally?

Stocks Soar to Record Highs, Gold Tops $4,000 – What’s Driving 2025’s Historic Rally?

Wall Street at Record Highs Amid AI Euphoria Wall Street’s 2025 rally has reached new heights. This week, U.S. stock indices pushed into uncharted territory, overcoming a brief stumble. After seven straight up sessions, the S&P 500 and Nasdaq Composite
9 October 2025
Adaptimmune Therapeutics (ADAP) Stock Skyrockets 42% – Is This Biotech Turnaround for Real?

Adaptimmune Therapeutics (ADAP) Stock Skyrockets 42% – Is This Biotech Turnaround for Real?

Therapy (Target) Indication Status (2025) Current Ownership TECELRA(afamitresgene, targets MAGE-A4) Synovial sarcoma (unresectable/metastatic) FDA approved Aug 2024 biospace.com; ~16 patients treated in launch year nasdaq.com. Sold to US WorldMeds (2025) adaptimmune.com Letetresgene (lete-cel, NY-ESO-1) MRCLS and synovial sarcoma (advanced solid tumors) Phase
8 October 2025
1 136 137 138 139 140 150
Go toTop